Phyllis Y. Chong
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Bioenergetic diversity and nutrient auxotrophy shape the metabolic landscape of multiple myeloma.
Journal: Blood advances
Published: July 07, 2025
Bioenergetic diversity and nutrient auxotrophy shape the metabolic landscape of multiple myeloma.
Journal: Blood advances
Published: July 07, 2025
Epigenetic dysregulation of eukaryotic initiation factor 3 subunit E (eIF3E) by lysine methyltransferase REIIBP confers a pro-inflammatory phenotype in t(4;14) myeloma.
Journal: Haematologica
Published: May 02, 2023
Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma.
Journal: Cancer research
Published: November 04, 2022
SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic PTP4A3 through Chromatin Remodeling in t(4;14) Multiple Myeloma.
Journal: Cancer research
Published: August 28, 2020
IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma.
Journal: Cancer research
Published: January 28, 2019
Non-canonical activation of β-catenin by PRL-3 phosphatase in acute myeloid leukemia.
Journal: Oncogene
Published: March 05, 2018
A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase.
Journal: Journal of hematology & oncology
Published: October 30, 2017
LIN28B Activation by PRL-3 Promotes Leukemogenesis and a Stem Cell-like Transcriptional Program in AML.
Journal: Molecular cancer research : MCR
Published: August 11, 2016
LEO1 is regulated by PRL-3 and mediates its oncogenic properties in acute myelogenous leukemia.
Journal: Cancer research
Published: April 02, 2014
Last Updated: 09/26/2026